The government has expanded the Pharmacy First scheme, allowing community pharmacists in England to assess and treat a larger group of conditions without a referral from a general practitioner (GP). The newly covered conditions include migraine, acne, scabies, ear infections and allergic rhinitis.

The scheme launched in January 2024 with seven conditions: sinusitis, sore throat, earache, infected insect bites, impetigo, shingles and uncomplicated urinary tract infections in women. The latest expansion extends that list considerably. Ministers describe the policy aim as making the local pharmacy the first point of contact for minor health concerns, which would reduce demand on GP surgeries and emergency departments.

Under the arrangements, a pharmacist carries out an initial consultation in a private room, decides whether the complaint falls within the scheme and supplies a prescription-only medicine where appropriate. Patients whose symptoms suggest something more serious are referred onward. In effect, the pharmacy acts as a triage unit in the community, and patients can walk in without an appointment.

England is following a model that Scotland has operated for longer. NHS Pharmacy First Scotland began in 2020 and allows pharmacists to manage a wide range of common clinical conditions, with Wales running a comparable common ailments service. Policymakers in England have treated those schemes as a working template. Compared with several other healthcare systems, pharmacists in the United Kingdom hold considerable authority to advise, supply and in some cases prescribe, which is the basis on which this expansion rests.

Professional bodies have raised concerns about clinical risk. Some doctors argue that conditions such as migraine can mask more serious neurological problems, and that skin complaints sometimes resemble conditions needing specialist review. They question whether a short consultation, however well conducted, gives a pharmacist the same diagnostic opportunity as a GP who knows a patient's history. Pharmacy representatives respond that referral protocols and additional training address this, and that pharmacists already spend years learning to recognise warning signs.

Funding is a separate point of dispute. Community Pharmacy England has said for some time that the sector is under financial strain, with reports of closures in recent years as dispensing margins tighten. Pharmacy First attracted dedicated funding when it launched, yet owners say that each consultation takes staff time and floor space that the fee may not fully cover. If participation proves uneconomic for some branches, access to the service could vary by area.

Supporters point to convenience. A patient with an ear infection or an allergic reaction can often be seen the same day, without waiting days for a GP appointment, and every minor case handled at a counter frees an appointment elsewhere. Early data from the scheme's first year showed millions of consultations delivered, which backers cite as evidence of public demand.

The expansion arrives against a long record of constrained health spending. The Institute for Fiscal Studies and the Health Foundation have both noted that NHS funding in England grew by an average of about 3.6 per cent a year in real terms across its history, but by roughly 1.5 per cent a year through the decade to 2019. Demand from an ageing population and rising chronic illness grew faster than that. The Covid-19 pandemic added a backlog of treatment that has yet to clear.

Successive governments have approached the problem differently. Capital budgets were cut or diverted to day-to-day spending for much of the 2010s, leaving a maintenance backlog in hospitals that now runs into billions of pounds. More recent settlements have increased cash funding, though analysts say the uplift has not made up for earlier shortfalls, and inflation has eroded part of it.

Health policy analysts generally accept that moving minor illness out of general practice has value. They also caution that it addresses only one part of the pressure on the system. Redirecting patients to pharmacies may shorten some queues, but it leaves unchanged the shortage of hospital capacity, the state of NHS buildings and the pace of workforce growth. On that view, Pharmacy First offers local relief, and lasting improvement depends on sustained investment in the wider service.

‍